Bromocriptine for prolactinoma-related dissociative disorder and depression.
Cohen
A J
AJ
D001971:Bromocriptine / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D004213:Dissociative Disorders / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D010911:Pituitary Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000097:blood / Q000188:drug therapy* / Q000523:psychology
D001971:Bromocriptine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone